N1-Methyladenosine (m1A) Regulation Associated With the Pathogenesis of Abdominal Aortic Aneurysm Through YTHDF3 Modulating Macrophage Polarization

Introduction

Abdominal Aortic Aneurysm (AAA) is a common vascular disease featured with the pathological dilatation of the abdominal aorta and the consistent weakening of the aortic wall (1). Currently in clinical cases, male patients with AAA diameter >5.5 cm, female patients with AAA diameter >5.0 cm as well as ruptured AAAs are only recommended to endovascular aneurysm repair (EVAR) or open surgical repair (OSR) (2, 3), due to the extreme lack of effective drug therapy (4). The Multi-center Aneurysm Screening Study (MASS) in 2012, a randomized controlled trial (RCT) of screening for AAA in a large UK population, showed a prevalence rate of an aortic aneurysm of 4.9% (5). Recent study has reported an AAA prevalence rate at 1.3–5% of screened men 65 years and older (6). However, once an AAA is detected, the average life expectancy for males is 11 years (7). Meanwhile, a ruptured AAA (rAAA) will result in a mortality rate of up to 81% for men (6).

Since the risks and limitations of surgical repairs in AAA treatment, together with the high mortality of rAAA are non-negligible and concerning, many fundamental researches have focused on the etiology of AAA in order to specifically inhibit the progression of AAA. Current theories on AAA pathogenesis indicate that AAA is mainly characterized by acquired immune-driven destruction of the aortic wall and a response to atherosclerosis and thrombosis, which cause the subsequent extracellular matrix (ECM) degradation, vascular inflammation, apoptosis of vascular smooth muscle cells (VSMCs) and abnormal oxidative stress response (8, 9). Moreover, inherited factors in AAA pathogenesis are gaining increasing attention from researchers nowadays. For example, significant single nucleotide polymorphisms (SNPs) related to AAA are identified in genome-wide association studies, proposing affected genes or proteins like IL-6 receptor, LDL receptor, SMYD3 and MMP-9 (8). mTORScholars also found that miR-424/322 provide protection against AAA formation by modulating the Smad2/3/runt-related transcription factor 2 axis, which implies the potential roles of epigenetic regulation in AAA progression (10).

Epigenetic regulation, including DNA methylation, RNA methylation, non-coding RNAs (ncRNAs), histone acetylation and deacetylation, etc., refers to regulating gene expression and structure without altering genome sequence, and thus affect human health and disease (11). Additionally, recent studies have shown that epigenetics is strongly associated with various vascular diseases. At chromatin level, study has demonstrated that histone acetylation and histone acetyltransferases play significant roles in human AAA (12). At mRNA level, increased N6-methyladenosine (m6A) modification level, 5-methylcytosine (m5C) methylation level and the up-regulating expression of their regulatory genes were verified in human AAA (13, 14). At ncRNAs level, Li et al. illustrated that miR-124a can involve in the regulation of Wnt/β-Catenin and P53 pathways to inhibit AAA via targeting BRD4 (15). Meanwhile, circular RNA expression and its potential regulation in AAA have attracted widespread attention as well (16).

Based on the existing findings of epigenetic regulation in AAA, we started to focus on other types of RNA methylation modifications in AAA, especially N1-Methyladenosine (m1A) modification. M1A modification changes the secondary structure of RNAs by adding a methyl group to the N1 position of adenosine, thus affecting the interaction between RNAs and proteins (17). M1A methylation is found in rRNAs, tRNAs, mRNAs and mitochondrial RNAs, regulated by three types of m1A regulators: First, m1A “writers,” including TRMT6/TRMT61A, TRMT61B, TRMT10C, BMT2 and RRP8, work as methyltransferases to add m1A modification on RNAs; Second, m1A “erasers,” containing FTO, ALKBH1-3, can eliminate the modification of m1A; Third, m1A “readers,” comprising YTHDF1-3 and YTHDC1, serve as RNA binding proteins which can read m1A methylation modification information as well as recognizing and binding to m1A methylation sites (17–19). Although m1A modification patterns have been reported in a variety of diseases, involving Ovarian Cancer, Pancreatic Cancer and Oral Squamous Cell Carcinoma (19–21), there are currently no relevant reports of m1A modification and regulation in AAA, motivating us to perform research on the role of m1A regulation in AAA.

In addition, inflammatory immune cell infiltration in aortic adventitia is a key characteristic of AAA (22). To be specific, studies have shown that macrophages play an essential role in the formation and development of AAA (23). Furthermore, the transition (also known as macrophage polarization) from M0 macrophages to pro-inflammatory M1 phenotype macrophages or anti-inflammatory M2 phenotype macrophages has been proved to have a regulatory effect on the vascular inflammation of AAA (24). It is worth mentioning that various epigenetic mechanisms are associated with macrophage polarization and can further regulate the inflammation in cardiometabolic and vascular diseases (25). Song et al. also confirmed that circular RNA Cdyl promotes AAA formation by inducing M1 macrophage polarization and M1-type inflammation (26), inspiring the idea of exploring and utilizing specific epigenetic mechanism to regulate macrophage polarization in AAA.

This study aimed to explore the possible epigenetic mechanism of m1A regulation in the pathogenesis of AAA, contributing to the development of AAA etiology from the perspective of m1A epigenetic regulation. First of all, our study used bioinformatics analysis and experimental validation at human tissue level to establish the research basis of the expression pattern of m1A regulators and their correlation with immune cells in AAA. Secondly, based on this research foundation, we chose to focus on YTHDF3, the m1A “reader,” and further explored its regulation of macrophage polarization in ex-vivo experiments. At last, RIP-Seq analysis of YTHDF3 combined with bioinformatics analysis was conducted to predict the AAA-related target genes of YTHDF3.

Materials and Methods

Data Sources and Screening of AAA-Related m1A Regulators

The gene expression profiling datasets GSE47472 and GSE98278 were acquired from the GEO database (https://www.ncbi.nlm.nih.gov/geo/) for analysis. Among them, GSE47472 included mRNA expression data from 14 AAA neck specimens and 8 normal aortic specimens of organ donors, while GSE98278 contained 48 AAA samples but no normal aortic samples. All data from these two chips were free to use and both of the chips were annotated with the same platform named Illumina HumanHT-12 V4.0 Expression Beadchip (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL10558). Thereafter, the raw data from these two datasets underwent data combination, background correction and quantile normalization by “limma” package in R. After preprocessing, the combined dataset consisted of 8 normal aortic samples and 62 AAA samples altogether, which was prepared for further analysis.

The overall differential gene expression analysis based on the combined dataset was performed with the statistical threshold of |log₂Fold Change (FC)|≥1 and adjusted P value <0.05 also by the “limma” R package. In this study, fourteen genes extracted from formal relevant reviews and research articles, including YTHDF1, YTHDF2, YTHDF3, RRP8, ALKBH1, ALKBH2, ALKBH3, YTHDC1, TRMT6, TRMT61A, TRMT61B, TRMT10C, FTO and BMT2, were regarded as common m1A RNA methylation regulators. Then, the differentially expressed m1A regulatory genes (DEMRGs) were identified via the overlapping of differentially expressed genes (DEGs) and 14 candidate m1A regulators. Due to their significantly differential expression level in AAAs, DEMRGs were also defined as AAA-Related m1A regulators.

Co-expression Analysis and Functional Annotation of AAA-Related m1A Regulators

Based on the DEMRGs and our combined dataset, co-expression analysis aiming to dig the co-expressed genes of DEMRGs in AAA tissues was carried out with “limma” and “Hmisc” packages within R. To be specific, the co-expression analysis was conducted using Pearson correlation as well as the cut-off criteria of |R| ≥ 0.8 and P < 0.05. After that, among the union set of co-expressed genes of all DEMRGs, we performed Gene Ontology (GO) enrichment analysis, which included terms of biological processes (BP), cellular components (CC), molecular functions (MF), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis utilizing “clusterProfiler” R package. The adjusted P < 0.05 together with q value < 0.05 was considered statistically significant and 15 terms with the top gene counts of each enrichment category were displayed.

A LASSO model was established to primarily screen the qualified biomarkers from AAA-Related m1A regulators in the diagnosis of AAA. The “glmnet” package in R software was used to establish the LASSO regression model (family = “binomial”) based on the gene expression profiles of DEMRGs and the status (AAA or normal) of all the samples. In the current study, the minimum lambda value (λ.min) judged by the minimum binomial deviance was used as a reference to identify the essential genes to be included in the AAA diagnostic model. Additionally, key genes obtained from the LASSO model were then used to conduct Receiver Operating Characteristic (ROC) curve analysis in order to quantitatively evaluate the diagnostic value of DEMRGs in AAA. The ROC curve model was established with HIPLOT online tools (https://hiplot.com.cn/basic/roc) and genes with Area Under Curve (AUC) more than 90% were reckoned as ideal diagnostic biomarkers in identifying AAA.

Analysis of Immune Cell Infiltration in AAA and the Correlation Between AAA-Related m1A Regulators and Immune Cells

Because inflammatory immune cell infiltration was a substantial characteristic of AAA pathology, we performed analysis of immune cell infiltration in AAA with CIBERSORT tool in R. CIBERSORT algorithm is an analytical tool from the Alizadeh Lab developed by Newman et al. to provide an estimation of the abundances of member cell types in a mixed cell population, using gene expression data (27). All the relevant R packages and files could be acquired from the CIBERSORT web portal (http://cibersort.stanford.edu/). The gene expression matrix of our combined dataset was input to R and the leukocyte signature matrix (LM22), which contains 547 genes that distinguish 22 human hematopoietic cell phenotypes, was selected as the signature gene file. Afterwards, the result of immune cell infiltration landscape in AAA and normal aortic tissue was output. Then, immune cell types with zero abundance value in more than half of the samples were regarded as extremely low proportion and were thus excluded from our research. The adjusted P < 0.05 was set as the threshold for statistical significance. The relative contents of diverse immune cell types in each sample were visualized as heat maps according to the research outcomes. Moreover, specific immune cell types with significant differences between AAA and normal samples were individually visualized as box plots.

Pearson correlation analysis was also performed to further explore the role of AAA-related m1A regulators during the development of AAA, participating in immune cell infiltration. The degree of correlation among immune cells was analyzed according to the relative proportion of immune cells in each sample. Besides, the relative content of each immune cell type and the expression data of DEMRGs were used to explore the relationship between AAA-Related m1A regulators and immune cells. The Pearson correlation coefficient (R) ≥ 0.45 together with adjusted P < 0.05 was considered as a significantly strong correlation.

Clinical Specimens Collection and Preprocessing

Our study obtained human AAA tissue from the clinical cases at the Department of Vascular Surgery, The First Hospital of China Medical University (CMU), undergoing the elective open surgical repair for aneurysm as previously described (14, 28). The AAA population selection and biopsy tissue collection were conducted by China Medical University Aneurysm Biobank (CMU-aB). However, patients with Marfan syndrome, Ehlers-Danlos syndrome, and other identified vascular or connective tissue disorders were excluded from the study. For the inclusive 141 AAA patients in CMU-aB, AAA was diagnosed by computed tomography angiography (CTA). All human AAA samples collection was conducted according to the guidelines from the World Medical Association Declaration of Helsinki. Meanwhile, normal abdominal aorta samples from 18 organ donors were used as the control tissue samples and this was conducted in accordance with the Declaration of Istanbul. Exclusion criteria for the control group included drug history, cancer, infection, and any additional immune-related diseases that might have negatively influenced the study. In addition, each case provided the informed consent for participation. Afterwards, we selected a total of 63 fresh AAA samples and 18 control samples to form our aneurysm biobank applied in this study. The Ethics Committees of the First Hospital of China Medical University approved our study protocol (ethical approval number: 2019-97-2).

All tissue samples were divided into two parts according to different experimental purposes and stored at −80°C condition. The first part consisted of 35 AAA samples and 8 control samples, which was used for total RNA extraction and subsequent reverse transcription PCR as well as RT-qPCR analysis. The second part contained 28 AAA samples and 10 control samples, prepared for protein extraction and quantitative Western blot (WB) analysis.

For the first part of tissue samples, total mRNA was extracted from aortic tissues utilizing TRIzol reagent (93289, Sigma-Aldrich, USA) according to the standard protocol. To ensure the accuracy of the subsequent experiments, only high-quality RNAs with their A260/A280 ratio >1.8 and <2.2 were qualified for use. Thereafter, PrimeScript™ RT Master Mix (RR036A, TaKaRa Bio, Shiga, Japan) was used to synthesize cDNA from total mRNA with the procedure of 15 min of reverse transcription reaction under 37°C followed by 5 s of inactivation of reverse transcriptase under 85°C. For the other part of tissue samples, proteins were extracted from fresh frozen tissues through RIPA lysis buffer (P0013B, Beyotime, Shanghai, China) and later the concentration of each sample was quantified by BCA Protein Assay kit (P0012, Beyotime, Shanghai, China). At last, all the measured protein samples were mixed with 5 ×SDS-PAGE Sample Loading Buffer (P0015, Beyotime, Shanghai, China) in a 4:1 volume ratio. All the cDNA and protein samples undergone preprocessing were then stored at −20°C.

Moreover, the typical 2–3 μm AAA tissue sections utilized to carry out Immunofluorescence (IF) staining analysis were acquired from FangDa Mass Hospital in Yingkou City, Liaoning Province.

Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR) Analysis

RT-qPCR method was applied in the detection of gene relative expression on mRNA level. For all of the tissue-derived samples and cell-derived samples included in the RT-qPCR analysis, the TB Green^® Premix Ex Taq ™ II plus Tli RNaseH (RR820A, TaKaRa Bio, Shiga, Japan) was utilized to conduct RT-qPCR in Applied Biosystems 7500 Real-Time PCR System (Thermo Fisher Scientific, USA) in accordance with the modified two-step amplification protocol. The RT-qPCR conditions were as follows: 30 s of initial denaturation under 95°C; followed by 5 s of denaturation under 95°C, and 34 s of annealing combined with extension under 60°C for 50 cycles. Housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as the internal control in every RT-qPCR test for normalization. Each pair of forward and reverse primers was provided by Sangon Biotech (Shanghai, China) and their sequences are shown in Table 1. The relative expression levels of mRNAs in samples were calculated with the 2^−ΔΔCT method.

TABLE 1

Table 1. Primer sequences used for RT-qPCR.

Western Blot (WB) Analysis

Western Blot (WB) staining has been widely used in the analysis of gene relative expression on protein level. Protein samples (20 μg of each lane) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using 5% spacer gel and 12% separation gel, then transferred onto polyvinylidene difluoride (PVDF) membrane. The membranes were blocked (5% skimmed milk powder in 1 ×TBS with 0.05% Tween 20) for 2 h, followed by incubation with primary antibody at a dilution of 1:1,000 for rabbit anti-YTHDF3 (K005805P, Solarbio, Beijing, China), anti-iNOS (BA0362, BOSTER, Wuhan, China) and 1:10,000 for rabbit anti-GAPDH (D110016, Sangon Biotech, Shanghai, China), anti-β-Actin (abs132001, absin, Shanghai, China), overnight at 4°C. The blots were then incubated with Horseradish Peroxidase (HRP)-labeled Goat Anti-Rabbit IgG (A0208, Beyotime, Shanghai, China) at a dilution of 1:1,000 for 1–2 h at room temperature (RT). After washing the membranes 3 times with Tris-buffered saline with Tween (TBST), immunoreactive bands were developed and detected using hypersensitive Electro Chemical Luminescence (ECL) kit (P1000-100, Applygen, Beijing, China) and the chemiluminescence detection system (FluorChem HD2, ProteinSimple, USA). The densitometry was performed with Image J software 1.53 (W. Rasband, Research Services Branch, NIMH, National Institutes of Health, Bethesda, MD, USA) and normalized to the signal intensity of GAPDH or β-Actin for equal protein loading control of each sample in each experiment.

Immunofluorescence (IF) Double Staining Analysis of CD68 and YTHDF3 in Human AAA Tissue

Since our bioinformatics analysis of immune cell infiltration in AAA revealed a strong correlation between macrophages and YTHDF3, IF double staining analysis of CD68 (surface marker of macrophages) and YTHDF3 was carried out for cellular localization in AAA tissue.

Firstly, typical 2–3 μm paraffin-embedded AAA sections were dewaxed and rehydrated in line with xylene, isopropanol and descending gradient ethanol. Then, the process of antigen epitopes retrieving was performed by boiling the sections within 0.01M citrate buffer (pH = 6.0). After rinsing by Tris-buffered saline (TBS), the exposed tissues were blocked by Immuno Staining Blocking Buffer (P0102, Beyotime, Shanghai, China) for 2 h, followed by incubation overnight using the rabbit anti-YTHDF3 antibody (dilution 1:100; K005805P, Solarbio, Beijing, China) at 4°C in the humidified chamber. After washing by TBS thrice, the Cy3 (red) conjugated Goat Anti-Rabbit IgG (dilution 1:400; GB21303, Servicebio, Wuhan, China) was utilized to incubate the sections for 2 h under RT, light-free condition. Afterwards, sections were washed 3 times with fresh TBS, and incubated with rabbit anti-CD68 antibody (dilution 1:200; abs120102, absin, Shanghai, China) overnight under 4°C in the humid chamber. Being rinsed thrice with TBS, sections were incubated with Goat anti-Rabbit IgG-AlexaFluor 488 (green, dilution 1:400; abs20025, absin, Shanghai, China) at RT condition away from light for another 2 h. The sections were finally washed three times with TBS, and stained by Antifade Mounting Medium with DAPI (P0131, Beyotime, Shanghai, China) for 10 min in a dark chamber. At last, the fluorescence microscope (Nikon, Tokyo, Japan) was used to observe sections and acquire photos of different visual fields.

Cell Culture and Induction of M1 Polarization

The murine macrophage cell line RAW264.7 was obtained from Fudancell (FuHeng BioLogy, FH0328, Shanghai, China) and cultured in 10 cm plates with complete growth medium DMEM High Glucose (MA0545, meilunbio, Dalian, China) containing 10% fetal bovine serum (10100-147, Gibco, Thermo Fisher Scientific, USA) and 1% Penicillin/Streptomycin (10,000 U/mL; SV30010, HyClone, USA) in humidified air with 5% CO₂ at 37°C. To inhibit the differentiation of RAW264.7 cell line, cell scrapers were used for cell subculturing instead of 0.25% Trypsin-EDTA.

Untreated RAWs were defined as M0 macrophages. 1 × 10⁶ M0 macrophages were seeded into each chamber of the 6-well plates for 12–24 h. When the cells were adherent, the previous complete growth medium was removed and treatment for M0 macrophages was placed as follows: control group, 2 mL of complete growth medium for each well only; M1 polarization group was induced by 100 ng/mL lipopolysaccharide (LPS; SMB00610, Sigma-Aldrich, USA) and 50 ng/mL recombinant murine interferon-gamma (IFN-γ; C600059, Sangon Biotech, Shanghai, China) with a total medium mixture volume of 2 mL. After applying the above intervention conditions, the cells were further cultured at 37°C and 5% CO₂ for 24 h, followed by total RNA extraction, protein extraction and cell culture supernatant collection according to the protocols mentioned in parts 2.4 and 2.10.

YTHDF3 siRNA Transfection and Further Induction of M1 Polarization

Small interfering RNA (siRNA) against mouse YTHDF3 as well as Negative Control (NC) siRNA was designed and synthesized by RiboBio (Guangzhou, China). The three siRNA sequences arranged for YTHDF3 mRNA silencing were ythdf3-si-1(5′-3′): ACUCAUUGGUUCCUUUAAGGG; (3′-5′): CUUAAAGGAACCAAUGAGUCC; ythdf3-si-2 (5′-3′): UGGAUUUGUACCAUUCUUCUG; (3′-5′): GAAGAAUGGUACAAAUCCAAG; ythdf3-si-3 (5′-3′): UCAUAUUCUGAAUCUCAUCCU; (3′-5′): GAUGAGAUUCAGAAUAUGAAG.

RAW264.7 cells were transfected with 50 nM YTHDF3 siRNAs or NC siRNAs for 48 h, using riboFECT^TM CP Transfection Kit (C10511-05, RiboBio, Guangzhou, China) in line with manufacturer's instructions. M0 macrophages were inoculated into 6-well plates at 5 × 10⁵ cells/well, and cultured overnight at 37°C in 5% CO₂ incubator. Total RNA, protein and cell culture supernatant samples were all extracted or collected after siRNA transfection, prepared for use in the further analysis. The RT-qPCR analysis was applied in the validation of YTHDF3 mRNA silencing efficiency. Additionally, positive control siRNA conjugated with Cy3 fluorophore (siT0000002-1-5, RiboBio, Guangzhou, China) was also used as the indication of successful transfection.

To further explore the role of YTHDF3 in macrophage M1 polarization, induction of M1 polarization (fresh medium with 100 ng/mL LPS and 50 ng/mL IFN-γ, incubating for 24 h) was performed again after 48 h of YTHDF3 siRNA transfection. Relevant samples were collected and stored for subsequent experiments.

Enzyme-Linked Immunosorbent Assay (ELISA) for IL-12 Expression Levels

The expression levels of macrophage M1-phenotype marker IL-12 in cell culture supernatant were tested through ELISA. To begin with, cell culture media was centrifuged at 2,000 rpm for 20 min under 4°C, and then supernatant was obtained and ready for detection after the removal of impurities and cell debris. We used Mouse IL-12 ELISA Kit (D721111, Sangon Biotech, Shanghai, China) which employs the sandwich enzyme immunoassay technique for ELISA, following the manufacturer's protocol. After the formation of immune complex and its chromogenic reaction with TMB, the absorbance (OD) value of each sample was measured at 450 nm. The concentration of IL-12 in the sample was proportional to the OD value and could be calculated by quantitative method of standard curve.

RNA Immunoprecipitation Sequencing (RIP-Seq) Analysis of YTHDF3

RIP experiments were performed using a Magna RIP RNA-binding Protein Immunoprecipitation Kit (Millipore, Billerica, MA, USA) in accordance with the manufacturer's instructions. First of all, nuclear protein was extracted from both AAA tissue and healthy aorta tissue for subsequent RIP-Seq. In brief, after coating with anti-YTHDF3 antibody (sc-377119, Santa Cruz Biotechnology, Dallas, USA) or corresponding NC IgG antibody (Millipore, Billerica, MA, USA), cell lysates from AAA group and normal aorta group were independently used to incubate the coated magnetic beads overnight under 4°C. Later, the specific binding of RNA-protein complexes was treated in accordance with specific protocol for the two types of purified co-precipitated RNAs, and the RNA content was then analyzed by adopting NanoDrop 2000c. Furthermore, we eliminated rRNAs from the immune-precipitated RNAs. Later, we commissioned SEQHEALTH Ltd. Co. (Wuhan, China; Contract No. KC2019-D146) to conduct RIP-transcriptome sequencing analysis of the two groups of our immune-precipitated RNAs and the subsequent bioinformatics analysis. The RIP-Seq results were then uploaded to NCBI Sequence Read Archive (SRA) database. At last, the YTHDF3-binding genes in AAA tissue and healthy aorta tissue were compared and the AAA-specific genes bound to YTHDF3 were identified.

The objective of RIP-Seq analysis of YTHDF3 was to explore the potential function of YTHDF3 by identifying the RNAs binding to YTHDF3 protein in human AAA. Finally, the result of RIP-Seq analysis of YTHDF3 was output and used for PPI network construction and the prediction of YTHDF3 downstream target genes in AAA progression.

Protein-Protein Interaction (PPI) Network Construction and Prediction of YTHDF3 Downstream Target Genes in AAA Progression

2298 AAA-specific genes binding to YTHDF3 were identified via RIP-Seq analysis. In order to dig the downstream target genes (DTGs) of YTHDF3 that also play substantial roles in AAA progression, key intersection genes were yielded through the overlapping of these 2,298 genes, upregulated DEGs in AAA and the positive co-expression genes of YTHDF3 in AAA.

The Search Tool for the Retrieval of Interacting Genes (STRING) database (https://www.string-db.org) was employed to construct a PPI network for key intersection genes. Thereafter, the PPI pairs were extracted using a combined score of >0.55. Subsequently, the YTHDF3-centric PPI network was visualized by Cytoscape 3.9.0 software (https://cytoscape.org/). According to the Maximal Clique Centrality (MCC) method and Degree method (Deg), CytoHubba was employed to calculate the MCC value as well as the degree of each protein node in the whole PPI network. Furthermore, MCODE, a plugin in Cytoscape, was utilized to analyze and visualize the sub-networks (highly interconnected clusters) in the PPI network. Lastly, nodes with the top 20 degrees or top 20 MCC values in the whole PPI network were defined as hub genes. These hub genes were also considered as DTGs of YTHDF3 that might participate in the progression of AAA.

Statistical Analysis

Statistical analysis was performed using SPSS 25.0 software (IBM Corp, Chicago, IL, USA) together with GraphPad Prism 8.0.1 software (GraphPad Software, San Diego, CA, USA) to evaluate differences among groups. Either the parametric Student's t-test for unpaired samples or the non-parametric Mann-Whitney U test was applied to analyze based on the distribution of variables. Comparisons among ≥3 groups were conducted using one-way ANOVA (with Brown-Forsythe test). For correlation analysis in our bioinformatics analysis section, correlations between different variables were analyzed through Pearson correlation analysis. A difference of P value <0.05 suggested statistical significance. All experiments were repeated in triplicates.

Results

Identification and Diagnostic Value Analysis of DEMRGs in AAA

Based on the combined dataset and the statistical threshold of |log₂FC| ≥ 1 and adjusted P < 0.05, the differential expression analysis of genes between AAA samples and controls was conducted, as shown in the heat map (Figure 1A) and volcano plot of DEGs (Figure 1C). Later, the overlapping between DEGs and 14 common m1A regulators was carried out and 8 DEMRGs were identified through the analysis. The expression pattern of DEMRGs was shown in the mosaic plot (Figure 1B) and volcano plot (Figure 1D). 8 DEMRGs, containing YTHDC1, YTHDF1-3, RRP8, TRMT61A, FTO, and ALKBH1, were distinctly displayed in Table 2. The significantly differential expression of DEMRGs between AAA groups and control groups was illustrated in box plots (Figures 2A–H).

FIGURE 1

Figure 1. Screening of differentially expressed m1A regulatory genes in AAA. (A) Overall heat map of the differential expression analysis; (B) The expression pattern of 14 common m1A regulators in AAA and control samples; (C) The volcano plot of DEGs in AAA, red represents up-regulated genes and blue represents down-regulated; (D) The volcano plot showing 8 DEMRGs in AAA, red represents up-regulated genes and blue represents down-regulated genes.

TABLE 2

Table 2. Identification of 8 AAA-related m1A regulators.

FIGURE 2

Figure 2. The differential expression level and diagnostic value of DEMRGs in AAA. (A) The up-regulating expression level of YTHDF1; (B) The up-regulating expression level of YTHDF2; (C) The up-regulating expression level of YTHDF3; (D) The down-regulating expression level of FTO; (E) The up-regulating expression level of YTHDC1; (F) The up-regulating expression level of RRP8; (G) The up-regulating expression level of TRMT61A; (H) The down-regulating expression level of ALKBH1; (I) The LASSO regression model established by 8 DEMRGs; (J) The coefficients plot of 8 DEMRGs in the LASSO model; (K) The ROC curves with AUC values of 6 key AAA-related m1A regulators.

The expression profile of the 8 DEMRGs was extracted and used to establish the LASSO model (Figures 2I,J). Then, 6 genes, including YTHDC1, YTHDF2-3, RRP8, FTO, and ALKBH1 were identified via the LASSO binomial regression analysis based on the value of λ.min = 0.001374812 and therefore were qualified for the further ROC curve analysis. Thereafter, ROC curve analysis demonstrated the AUC value of ALKBH1 (96.37), YTHDF3 (95.77%), YTHDC1 (91.94%), YTHDF2 (87.10%), FTO (81.05%), and RRP8 (80.04%), indicating ALKBH1, YTHDF3 and YTHDC1 may serve as potential biomarkers of AAA with high diagnostic values (Figure 2K). To be specific, YTHDF3 has the highest diagnosis value (with AUC > 95%) among all the up-regulated DEMRGs, which implies the significance of studying the potential function of YTHDF3 in our subsequent analysis.

Functional Enrichment and Pathway Analysis of Co-expressed Genes of DEMRGs

After the co-expression analysis of all the DEMRGs, a union set of 7,237 co-expressed genes were yielded and then input into the gene pool which was used for GO and KEGG enrichment analysis (Supplementary Material 1). As indicated by GO analysis, these co-expressed genes were mainly involved in BPs, including RNA catabolic process, neutrophil-mediated immunity, protein targeting, regulation of cellular amide metabolic process and regulation of cell cycle phase transition. In terms of CCs, these genes were mostly enriched in the mitochondrial inner membrane, mitochondrial matrix, cell-substrate junction and focal adhesion. With regard to MFs, these genes were mainly enriched in transcription co-regulator activity, GTPase regulator activity, cadherin binding and ubiquitin protein ligase binding, etc. Additionally, the KEGG pathway enrichment results showed that these genes were significantly enriched in pathways participated in chemical carcinogenesis-reactive oxygen species (ROS), endocytosis and protein processing in endoplasmic reticulum (ER). The outcome of functional enrichment and pathway analysis of co-expressed genes was presented in Supplementary Material 2 and Table 3.

TABLE 3

Table 3. GO and KEGG enrichment terms of co-expressed genes of DEMRGs.

Results of Immune Cell Infiltration and Its Correlation With DEMRGs in AAA

Through the immune cell infiltration analysis, the relative contents of 22 types of immune cells in 62 AAA samples and 8 normal samples were calculated by the CIBERSORT algorithm (Figure 3A). The landscape of immune infiltration in AAA tissues indicated the significantly higher relative proportions of M0 macrophages, M1 macrophages, plasma cells and activated mast cells in AAA than normal tissues (Figures 3C–F). Moreover, after filtering out 8 immune cell types with extremely low proportions, the Pearson correlation analysis was performed to evaluate the correlation among immune cells as well as the correlation between DEMRGs and immune cells in all samples (Figures 3B, 4I). For example, activated dendritic cells were markedly positively correlated with naive B cells (R = 0.53) and monocytes (R = 0.49); M0 macrophages were significantly correlated with activated mast cells (R = 0.47).

FIGURE 3

Figure 3. The immune infiltration landscape of AAA. (A) The composition of 22 types of immune cells in each sample; (B) The correlation among immune cells in AAA samples, with red representing positive correlation and blue representing negative correlation. Correlation results that were not statistically significant were shown as blank; (C) The content of M0 macrophages in normal aortic samples and AAA samples; (D) The content of M1 macrophages in normal aortic samples and AAA samples; (E) The content of plasma cells in normal aortic samples and AAA samples; (F) The content of activated mast cells in normal aortic samples and AAA samples.

FIGURE 4

Figure 4. The relationships between DEMRGs and immune cells. (A) Scatter plot of the correlation between YTHDF3 and activated mast cells; (B) Scatter plot of the correlation between YTHDF3 and plasma cells; (C) Scatter plot of the correlation between YTHDF3 and regulatory T cells (Tregs); (D) Scatter plot of the correlation between YTHDF3 and M1 macrophages; (E) Scatter plot of the correlation between YTHDF1 and M1 macrophages; (F) Scatter plot of the correlation between YTHDF2 and M1 macrophages; (G) Scatter plot of the correlation between YTHDF1 and M2 macrophages; (H) Scatter plot of the correlation between YTHDF3 and M2 macrophages; (I) Correlation heat map of the relationships between DEMRGs and immune cells, with red representing positive correlation, blue representing negative correlation and NA representing no statistical significance.

As for the relationship between DEMRGs and immune cells, we found that YTHDF3 had the most significantly positive correlation with various immune cells, such as activated mast cells (R = 0.73), Treg cells (R = 0.59), plasma cells (R = 0.52), M1 macrophages (R = 0.53), and M2 macrophages (R = 0.51). Among these immune cells, macrophages served as the appropriate research subject for the further analysis of YTHDF3's regulatory effect, due to its known important role in the formation and progression of AAA. Besides, some of the typical correlations between DEMRGs and immune cells were presented in scatter diagrams (Figures 4A–H).

The mRNA Expression Levels of Up-Regulated DEMRGs in AAA Samples

Thereafter, 6 up-regulated DEMRGs, including YTHDC1, YTHDF1-3, RRP8, and TRMT61A, were validated by RT-qPCR analysis for their relative expression at mRNA level (Figure 5). In our current study, the mRNA expressions of YTHDC1, YTHDF1, and YTHDF3 were observed up-regulating in the AAA tissue samples relative to normal tissues (FC = 4.606, P = 0.043; FC = 26.927, P value = 0.031; FC = 5.426, P = 0.043). Differences in YTHDF2, RRP8, and TRMT61A at mRNA levels were not significant (P = 0.364, P = 0.567, and P = 0.775).

FIGURE 5

Figure 5. The validation of the expression of DEMRGs at mRNA level in AAA tissue samples compared with the healthy control aortic samples, analyzed by RT-qPCR. (A) The relative expression of YTHDC1 in two groups; (B) The relative expression of YTHDF1 in two groups; (C) The relative expression of YTHDF3 in two groups; (D) The relative expression of YTHDF2 in two groups; (E) The relative expression of RRP8 in two groups; (F) The relative expression of TRMT61A in two groups. *P < 0.05.

Hence, 3 AAA-Related m1A regulators named YTHDC1, YTHDF1, and YTHDF3 were validated as up-regulated DEMRGs in our AAA samples.

The Protein Expression and Cellular Localization of YTHDF3 in AAA Tissues

We selectively performed Western Blot analysis for YTHDF3 in AAA and normal aorta tissues, because of its potential high diagnostic value, its strong positive correlation with immune infiltration and its up-regulating expression at mRNA level in human AAAs. Figures 6A,B displayed the blot images of YTHDF3 and its relative expression levels measured through Western blotting in all samples. The protein expression level of YTHDF3 in AAA tissue samples was significantly increased compared with healthy control aortic tissue samples (FC = 3.475, P = 0.012), in accordance with the RT-qPCR result.

FIGURE 6

Figure 6. The expression of YTHDF3 at protein level and its cellular localization in AAA tissues. (A) The images of Western Blot staining for YTHDF3 and GAPDH in each sample; (B) The box plot showing the relative expression of YTHDF3 (normalized to the signal intensity of GAPDH) in AAA and normal aortic samples; (C) The photographs of immunofluorescence for human AAA sections stained with CD68, YTHDF3 and 4', 6-diamidino-2-phenylindole (DAPI). *P < 0.05.

Later, to further validate the relationship between YTHDF3 and macrophages, the AAA wall co-localization of YTHDF3 with macrophage surface marker CD68 was examined using IF double staining analysis (Figure 6C). The IF result showed a significant infiltration of macrophages in AAA adventitia. Here, we could also clearly observe that YTHDF3 and CD68 were co-expressed in the one cell in AAA adventitia, which indicated the potential significance of studying the role of YTHDF3 in macrophage functions.

The Up-Regulation Relative Expression of YTHDF3 Associated With Macrophage M1 Polarization

Since the immune cell infiltration analysis together with the IF experiment illustrated the strong correlation between YTHDF3 and M1/M2 macrophages, we started to focus on the association between YTHDF3 and macrophage pro-inflammatory M1 polarization, which was involved in the immune-driven destruction of the aortic wall. Firstly, after the LPS/IFN-γ stimulus, the expression of M1 phenotype marker CD86 and IL12 significantly increased, indicating an ideal M1 macrophages experimental model (Figures 7A,B). Thereafter, the relative expression of YTHDF3 in M0 macrophage and M1 macrophage was determined by Western Blot analysis and the result showed an up-regulating tendency of YTHDF3 in M1 macrophage than M0 macrophage (FC = 1.412) but with the P = 0.149 (Figures 7C,D).

FIGURE 7

Figure 7. The induction of macrophages M1 polarization and the determination of YTHDF3 expression in M0 and M1 macrophages. (A) The expression of M1 phenotype marker, CD86, in M0 macrophages and LPS/IFN-γ induced M1 macrophages, measured by RT-qPCR; (B) The expression of M1 phenotype marker, IL12, in M0 macrophages and LPS/IFN-γ induced M1 macrophages, measured by ELISA; (C) The images of Western Blot staining for YTHDF3 and β-Actin, in M0 and LPS/IFN-γ induced M1 macrophages; (D) The relative expression of YTHDF3 (normalized to the signal intensity of β-Actin) in M0 and LPS/IFN-γ induced M1 macrophages. LPS, lipopolysaccharide; IFN-γ, interferon-γ. **P < 0.01, ***P < 0.001.

The Role of YTHDF3 in the M1/M2 Phenotype Transition of M0 Macrophage

For the aim of further exploring the mechanism underlying the regulation of YTHDF3 in macrophage M1/M2 polarization, siRNA transfection experiment was performed to specifically knock down the expression of YTHDF3 in RAW264.7 cells. The RT-qPCR result of YTHDF3 indicated an ideal ythdf3 knockdown efficiency (FC = 0.199, P < 0.0001, Supplementary Material 3). Later, the RT-qPCR analysis was conducted to analyze the relative expression of M1 phenotype markers (CD86, iNOS, TNFα) and M2 phenotype markers (CD206, Arg-1, TGFβ). The results demonstrated that siRNA knockdown of YTHDF3 inhibited macrophages M1 polarization and at the same time promoted macrophages M2 polarization (Figures 8A,B).

FIGURE 8

Figure 8. The role of YTHDF3 in the M1/M2 polarization of M0 macrophages. YTHDF3; (A) The relative expression of M1 phenotype markers (CD86, iNOS and TNFα) in M0 macrophages and si-ythdf3 macrophages, analyzed by RT-qPCR; (B) The relative expression of M2 phenotype markers (CD206, Arg-1 and TGFβ) in M0 macrophages and si-ythdf3 macrophages, analyzed by RT-qPCR; (C) The images of Western Blot staining for iNOS and β-Actin, in M0 macrophages, LPS/IFN-γ induced M1 macrophages and si-ythdf3+M1 polarization macrophages; (D) The relative expression of iNOS (normalized to the signal intensity of β-Actin) in M0 macrophages, LPS/IFN-γ induced M1 macrophages and si-ythdf3+M1 polarization macrophages; (E) The expression of IL12 in M0 macrophages, LPS/IFN-γ induced M1 macrophages and si-ythdf3+M1 polarization macrophages, measured by ELISA. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; iNOS, inducible nitric oxide synthase; TNFα, tumor necrosis factor-α; Arg-1, arginine-1; TGFβ, transforming growth factor-β.

YTHDF3 Knockdown Impaired LPS/IFN-γ Induced Macrophage M1 Polarization

For the YTHDF3 knockdown group, subsequent induction of macrophage M1 polarization was carried out and the expression of Inducible Nitric Oxide Synthase (iNOS, NOS2) and Interleukin 12 (IL12), two of the biomarkers and functional products of M1 macrophages, was tested through Western Blot and ELISA. The comparisons were performed among si-ythdf3+M1 polarization macrophage group, M1 macrophage group and M0 macrophage group. The result showed that YTHDF3 knockdown significantly impaired LPS/IFN-γ induced macrophage M1 polarization, and meanwhile attenuated the secretion of inflammatory factor IL12, significantly reversing the M0 to M1 polarization of macrophages (Figures 8C,E).

The RIP-Seq Results and the Prediction of YTHDF3 Downstream Targets Participating in AAA Progression

First of all, the RIP-Seq result of YTHDF3 in AAA tissue and healthy control sample was independently uploaded to the dataset SRX9734810 and SRX9734811, respectively, in NCBI SRA database. Afterwards, 2,298 AAA-specific YTHDF3-binding genes were yielded via the comparison with control group (Supplementary Material 4). Then, the overlapping of AAA-specific YTHDF3-binding genesYTHDF3, up-regulated DEGs in AAA and positively co-expressed genes of YTHDF3 in AAA was conducted to obtain an intersection of 681 genes (Figure 9A). In addition, these 681 key intersection genes and YTHDF3 were input into the STRING database to construct a PPI network (Supplementary Material 5). The two-level PPI network centered on YTHDF3 was visualized by Cytoscape (Figure 9B). Thereafter, hub genes with top 20 MCC values or node degrees were identified and visualized in circular networks by CytoHubba (Figures 9C,D and Tables 4, 5). After the combination of two hub gene lists, the final 30 hub genes were predicted as YTHDF3 downstream target genes (DTGs) participating in AAA progression. At last, MCODE plugin in Cytoscape was used to perform sub-network analysis of the whole PPI network. The sub-network with the highest cluster score was displayed in Figures 9E,F and hub genes identified by MCC method and Degree method were marked yellow in the diagram, respectively.

FIGURE 9

Figure 9. The construction of PPI network based on the RIP-Seq result and the prediction of YTHDF3 downstream targets participating in AAA progression. (A) The Venn diagram showing the overlapping of the AAA-specific YTHDF3-binding genesYTHDF3, YTHDF3 co-expressed (+) genes and up-regulated DEGs in AAA. (B) The two-level PPI network centered on YTHDF3; (C) The interactions among proteins with the top 20 MCC values in the whole PPI network. Red represents higher MCC values and yellow represents lower MCC values; (D) The interactions among proteins with the top 20 node degrees in the whole PPI network. Red represents higher node degrees and yellow represents lower node degrees; (E) The sub-network with the highest cluster score in the whole PPI network. Hub genes (identified by MCC method) existing in this sub-network were marked yellow; (F) The sub-network with the highest cluster score in the whole PPI network. Hub genes (identified by Degree method) existing in this sub-network were marked yellow. MCC, Maximal Clique Centrality.

TABLE 4

Table 4. Hub Genes with the Top 20 MCC values in the PPI network.

TABLE 5

Table 5. Hub genes with the Top 20 degrees in the PPI network.

Discussion

Abdominal aortic aneurysm (AAA) is a severe vascular disease that can carry extremely high mortality rates (8). Currently, there remains a paucity of medical therapies to help mitigate the rate of aneurysm growth and prevent AAA rupture (29). However, the consistent research progress on the roles of epigenetic regulation, especially RNA methylation in AAA pathogenesis, has opened up new therapeutic possibilities of AAA. For instance, Zhong et al. pointed out that METTL3 induces AAA development by modulating N6-Methyladenosine (m6A)-dependent primary miR34a processing (30). Similar to m6A modification, N1-Methyladenosine (m1A) is a typical type of RNA methylation, executing its biological functions through post-transcriptional regulation. Besides its role in tumorigenesis and many other biological processes (31), characteristic m1A modification and regulation have been reported in the pathophysiology of various cardiovascular diseases (CVDs) (17, 32, 33). Hence, it is of great significance to explore the role of m1A regulation in AAA occurrence and development.

First of all, in the bioinformatics analysis part of this study, we identified 8 DEMRGs and their co-expressed genes, followed by the GO/KEGG enrichment analysis. The result indicated that these m1A regulators and their related genes were significantly associated with biological processes like neutrophil activation/neutrophil-mediated immunity, ncRNA metabolic process and regulation of cell cycle phase transition. Scientists have found that the number of neutrophils and neutrophil-lymphocyte ratio is not only correlated with in-hospital mortality in symptomatic unruptured AAA patients (34), but also the overall mortality after endovascular AAA repair (35). Therefore, m1A regulators and their related genes probably influence the prognosis of AAA via regulating the immune infiltration in AAA. In addition, the ncRNA regulation of programmed cell death in VSMCs is gaining increasing attention nowadays. Le et al. and Wang et al. illustrated that long non-coding RNA (lncRNA) GAS5 is able to regulate human aortic smooth muscle cells (HASMCs) apoptosis and proliferation through the miR-185-5p/ADCY7miR-185-5p/ADCY7 axis, thus promoting AAA formation (36, 37). From this perspective, our study implied that the interplay between m1A regulation and non-coding RNAs may cause the programmed cell death of VSMCs by modulating the cell cycle phase transition. Furthermore, enrichment analysis showed that DEMRGs and their related genes were highly expressed in the cellular components including cell-substrate junction and focal adhesion, then executive molecular function like cadherin binding and participate in cell communication. A variety of studies have proved that the intercellular interaction and cell communication among VSMCs, immune cells and human aortic endothelial cells (hAECs) are strongly associated with AAA progression (38, 39). The KEGG pathway enrichment indicated a significant involvement of m1A regulators and their regulatory genes in pathways of reactive oxygen species (ROS), which is considered as a key factor of vascular oxidative stress, contributing to AAA pathogenesis (40, 41).

Secondly, RT-qPCR analysis verified that three of the m1A regulators, named YTHDC1, YTHDF1 and YTHDF3, were up-regulated in AAAs at mRNA level. YTHDC1, YTHDF1 and YTHDF3, both containing the YTH (YT521-B homology) domain, belong to the “readers” family of m1A methylation, functioning as methylation recognition enzymes that can read methylation sites and corporate with methylases (proteins of “writers” family) (17). YTHDC1 may participate in the RNA alternative splicing and affect the export of methylated mRNA from the nucleus to the cytoplasm, acting as the biomarker of prostate cancer and colon adenocarcinoma (42). YTHDF1 and YTHDF3 have all been identified as translation regulators, which are responsible for interacting with different mRNA targets (43). Besides, while YTHDF1 functions in translation regulation, its partner, YTHDF3, can serve as a hub for fine-tuning the RNA accessibility of YTHDF1, significantly promoting the translation of its target mRNAs by interacting with YTHDF1 (42). Other reports also demonstrated that cytoplasmic YTHDF3 promotes mRNA translation in synergy with YTHDF1, meanwhile affecting methylated mRNA decay mediated through YTHDF2 and serves as an initiation factor of protein synthesis from circRNAs in human cells (44–46). For the potential roles of YTHDF3 in cardiovascular diseases, genome-wide association studies (GWAS) showed that SNP rs4739066 on YTHDF3 is significantly associated with myocardial infarction (MI) and Shi et al. also found that YTHDF3 is dramatically differentially expressed in MI tissues compared with normal controls (47, 48).

Recent studies have frequently associated m1A regulator-mediated modification patterns with tumor microenvironment-infiltrating immune cells or other immunological characteristics in cancers like Colon Cancer and Ovarian Cancer (19, 49). According to the first part of our bioinformatics analysis, we also concluded that m1A regulators and their related genes were significantly associated with the regulation of innate immunity and immune cells in AAA. Additionally, the role of aortic wall inflammation together with the immune infiltration in the abdominal aorta was reckoned as having high diagnostic and therapeutic potential of AAA (50, 51). As a result, we further conducted the immune infiltration analysis of AAA to explore the immune landscape of AAA as well as the correlation between key AAA-related m1A regulators and immune cells. Then, M0 macrophages, M1 macrophages, plasma cells and activated mast cells were identified as significant immune infiltrates cells in AAA. This result also reflected the diverse roles of macrophages polarization in AAA pathogenesis (24, 52, 53). However, due to the lack of relevant reports, the role of activated mast cells and plasma cells in AAA pathogenesis remains unclear. From this perspective, focusing on the relationship between macrophages and key AAA-related m1A regulators, we revealed a strong positive correlation between YTHDF3 and M1/M2 macrophages and validated it in human AAA tissues. Therefore, in order to further explore the m1A regulation of macrophages polarization, YTHDF3 and macrophages were both selected as the research subjects for our subsequent in-vitro experiments.

Through the analysis after M1 polarization of RAW264.7 cells and the knockdown of ythdf3, YTHDF3 was verified to have a positive correlation with M1 macrophages and play an essential role in the promotion of macrophages M1 polarization. This finding provides a potential strategy of targeted therapy for AAA. To be specific, the specific knockdown of ythdf3 in macrophages can effectively inhibit macrophage M1 polarization and facilitate M2 polarization. Therefore, the specific inhibitor of YTHDF3 expression may serve as a modulator in the adaption of macrophage M2 polarization, which will decrease the secretion of matrix metalloproteinases (MMPs), facilitate reparative processes in aortic wall and attenuate the vascular inflammation by down-regulating the expression level of inflammatory cytokines like IL1β and TNF, up-regulating the secretion of anti-inflammatory cytokines and chemokines like IL10 and TGFβ (24, 54, 55). To sum up, YTHDF3 has the potential to become a novel therapeutic target for AAA due to its modulation of macrophages polarization and the restoration of the M1 phenotype/M2 phenotype ratio at the site of AAA.

Lastly, we performed RIP-Seq analysis for YTHDF3 and then used bioinformatics methods for PPI network analysis to dig the potential downstream target genes (DTGs) of YTHDF3. Thereafter, several DTGs of YTHDF3 comprising mTOR, CD44, ITGB1, ITGAVITGAV, STAT1, and STAT3, etc. were identified to play potential roles in AAA formation and development. As for CD44, studies have proved that an enhanced expression of CD44 exists in AAA, participating in the chronic vascular inflammation and the appearance of ectopic adipocytes in AAA wall (56, 57). Macrophages, as the major source of abundant CD44, can express various CD44 variants, especially soluble CD44, to stimulate the expression and release of pro-inflammatory cytokine, IL1β, from ECs (56). It is also worth mentioning that novel chemo-photothermal synergistic therapy targeted on CD44-positive inflammatory macrophages is being developed for the treatment of atherosclerosis (58). In addition, mTOR, a signaling molecule also called the mechanistic target of rapamycin, has been identified as a key factor in the PI3K/Akt/mTOR or the AMPK/mTOR signaling pathway (59, 60). The overactivation of mTOR signaling accelerates AAA expansion via affecting the phenotype transition of VSMCs, macrophages infiltration, MMPs expression, and inflammatory cytokine production (61). Hence, mTOR is also reckoned as a potential target for AAA drug therapy including rapamycin, metformin (MET) and Gambogic acid (59, 60, 62). As for the integrin family (including ITGB1, ITGAV, ITGA1, etc.), Zheng et al. showed that the activation of integrin/CD44 pathway will stimulate autophagy in VSMCs, facilitating the development of AAA (63). Scholars also found that the deficiency of specific integrin genes or the inhibition of integrin signaling pathways may ameliorate AAA progression by attenuating the infiltration of macrophages and decreasing the expression and activity of MMPs as well as reducing ECM degradation (64–67). Besides, the wide involvement of JAK-STAT pathway in AAA can modulate cytokine expression and immune cell activation, thus influencing the progression of AAA (68). Wu et al. and Xiao et al. independently pointed out that the blocking of JAK2/STAT3 will result in the inhibition of experimental AAA growth through modulating aortic inflammation (69, 70). There are also reports about the role of STAT1/STAT3 in the regulation of macrophages M1/M2 ratio (71–74), which imply the potential molecular mechanism underlying YTHDF3-modulated macrophage polarization, participating in the pathophysiological processes in AAA development.

Overall, our research is the first to observe that N1-Methyladenosine (m1A) regulators related genes are associated with the pathogenesis of abdominal aortic aneurysm through YTHDF3 modulating macrophage polarization. Since the primary function of YTHDF3 in macrophages is illustrated and the AAA-related target genes of YTHDF3 are predicted, we believe the m1A regulation mechanism regarding YTHDF3 will provide innovative potential targets for AAA therapy via adapting macrophage phenotypes. However, further research attempts are required to overcome the limitations of this study. For one thing, in-vivo experiments in animal models are required to confirm the regulatory effect of YTHDF3 on macrophages polarization and AAA progression. For another, the detailed m1A epigenetic mechanism centered on the interaction between YTHDF3 and other regulators, regulating the translation of target transcripts, needs to be explored through following research. Moreover, the m1A regulation involved in the interplays among macrophages, vascular endothelial cells (ECs), VSMCs and immune cells is also worth studying. Further research progress may shed some light on the role of m1A epigenetic regulation in AAA etiology as well as its promising future in the treatment of AAA.

Conclusion

Our study for the first time systematically analyzed the expression pattern of m1A regulatory genes in human abdominal aortic aneurysms and identified the key AAA-related m1A regulators. The research results showed that YTHDC1, YTHDF1 and YTHDF3 may act as m1A “readers” to regulate their related genes via m1A modification, participating in the pathogenesis of human AAA. Moreover, the correlation between key AAA-related m1A regulators and immune cells were revealed by immune infiltration analysis in AAA. Thereafter, the significant correlation between YTHDF3 and macrophages was verified in human AAA tissues. Now, we have found that YTHDF3 may play an essential role in the pathogenesis of AAA by promoting macrophage pro-inflammatory M1 polarization. Our research provided novel insights into the etiology of AAA from the aspect of m1A epigenetic regulation of macrophage polarization. Our studies also paved the way for better understanding the molecular mechanism lying under YTHDF3-modulated macrophage polarization and exploring the genes targeted for m1A RNA methylation modifications that are able to impact AAA progression.

Data Availability Statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Ethics Statement

The studies involving human participants were reviewed and approved by the Ethics Committees of the First Hospital of China Medical University (Ethical Approval No: 2019-97-2). The patients/participants provided their written informed consent to participate in this study.

Author Contributions

JZ and YH: conceptualization and funding acquisition. YW, FY, and SL: bioinformatics analysis. YW, DJ, HZ, and YY: experimental methodology. YW, HZ, and PG: data analysis. YW, DJ, and XZ: writing—original draft preparation. CB and CC: manuscript editing. DB, JZ, and YH: supervision. All authors have reviewed and approved the final version of the manuscript.

Funding

This work was supported by the Fundamental Research Funds for the Central University (Grant No: DUT19RC(3)076), the National Natural Science Foundation of China (Grant No: 81600370), and the China Postdoctoral Science Foundation (Grant No: 2018M640270) for YH.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We would like to thank the Gene Expression Omnibus (GEO) database for the precious data used for free in scientific research.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcvm.2022.883155/full#supplementary-material

Supplementary Table 1. The union set of co-expressed genes of DEMRGs.

Supplementary Table 2. The AAA-specific YTHDF3-binding mRNAs identified by RIP-Seq.

Supplementary Table 3. Node proteins in the PPI network.

Supplementary Figure 1. The GO/KEGG enrichment results of co-expressed genes of DEMRGs.

Supplementary Figure 2. The relative expression of YTHDF3 in M0 macrophages and si-ythdf3 macrophages, analyzed by RT-qPCR.

References

1. Thompson RW, Geraghty PJ, Lee JK. Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr Probl Surg. (2002) 39:110–230. doi: 10.1067/msg.2002.121421

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Rokosh RS, Wu WW, Eskandari MK, Chaikof EL. Society for vascular surgery implementation of guidelines in abdominal aortic aneurysms: preoperative surveillance and threshold for repair. J Vasc Surg. (2021) 74:1053–4. doi: 10.1016/j.jvs.2021.04.068

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Rokosh RS, Starnes BW, Chaikof EL. Society for Vascular Surgery implementation of clinical practice guidelines for patients with an abdominal aortic aneurysm: repair of an abdominal aortic aneurysm. J Vasc Surg. (2021) 73:1485–7. doi: 10.1016/j.jvs.2020.12.103

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Golledge J, Moxon JV, Singh TP, Bown MJ, Mani K, Wanhainen A. Lack of an effective drug therapy for abdominal aortic aneurysm. J Intern Med. (2020) 288:6–22. doi: 10.1111/joim.12958

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Kapila V, Jetty P, Wooster D, Vucemilo V, Dubois L. Screening for abdominal aortic aneurysms in Canada: 2020 review and position statement of the Canadian Society for Vascular Surgery. Can J Surg. (2021) 64:E461–e6. doi: 10.1503/cjs.009120

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Bains P, Oliffe JL, Mackay MH, Kelly MT. Screening older adult men for abdominal aortic aneurysm: a scoping review. Am J Mens Health. (2021) 15:15579883211001204. doi: 10.1177/15579883211001204

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Ashton HA, Gao L, Kim LG, Druce PS, Thompson SG, Scott RA. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br J Surg. (2007) 94:696–701. doi: 10.1002/bjs.6029

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol. (2019) 16:225–42. doi: 10.1038/s41569-018-0114-9

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Gurung R, Choong AM, Woo CC, Foo R, Sorokin V. Genetic and epigenetic mechanisms underlying vascular smooth muscle cell phenotypic modulation in abdominal aortic aneurysm. Int J Mol Sci. (2020) 21:6334. doi: 10.3390/ijms21176334

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Tsai HY, Wang JC, Hsu YJ, Chiu YL, Lin CY, Lu CY, et al. miR-424/322 protects against abdominal aortic aneurysm formation by modulating the Smad2/3/runt-related transcription factor 2 axis. Mol Ther Nucleic Acids. (2022) 27:656–69. doi: 10.1016/j.omtn.2021.12.028

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Mangum KD, Farber MA. Genetic and epigenetic regulation of abdominal aortic aneurysms. Clin Genet. (2020) 97:815–26. doi: 10.1111/cge.13705

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Han Y, Tanios F, Reeps C, Zhang J, Schwamborn K, Eckstein HH, et al. Histone acetylation and histone acetyltransferases show significant alterations in human abdominal aortic aneurysm. Clin Epigenetics. (2016) 8:3. doi: 10.1186/s13148-016-0169-6

PubMed Abstract | CrossRef Full Text | Google Scholar

13. He Y, Zhang H, Yin F, Guo P, Wang S, Wu Y, et al. Novel insights into the role of 5-Methylcytosine RNA methylation in human abdominal aortic aneurysm. Front Biosci. (2021) 26:1147–65. doi: 10.52586/5016

PubMed Abstract | CrossRef Full Text | Google Scholar

14. He Y, Xing J, Wang S, Xin S, Han Y, Zhang J. Increased m6A methylation level is associated with the progression of human abdominal aortic aneurysm. Ann Transl Med. (2019) 7:797. doi: 10.21037/atm.2019.12.65

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Li Y, Lv M, Lu M, Guan H. miR-124a involves in the regulation of Wnt/β-Catenin and P53 pathways to inhibit abdominal aortic aneurysm via targeting BRD4. Comput Math Methods Med. (2022) 2022:9241959. doi: 10.1155/2022/9241959

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Han Y, Zhang H, Bian C, Chen C, Tu S, Guo J, et al. Circular RNA expression: its potential regulation and function in abdominal aortic aneurysms. Oxid Med Cell Longev. (2021) 2021:9934951. doi: 10.1155/2021/9934951

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Zhou W, Wang C, Chang J, Huang Y, Xue Q, Miao C, et al. RNA Methylations in cardiovascular diseases, molecular structure, biological functions and regulatory roles in cardiovascular diseases. Front Pharmacol. (2021) 12:722728. doi: 10.3389/fphar.2021.722728

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Cao J, Shu X, Feng XH, Liu J. Mapping messenger RNA methylations at single base resolution. Curr Opin Chem Biol. (2021) 63:28–37. doi: 10.1016/j.cbpa.2021.02.001

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Liu J, Chen C, Wang Y, Qian C, Wei J, Xing Y, et al. Comprehensive of N1-Methyladenosine modifications patterns and immunological characteristics in ovarian cancer. Front Immunol. (2021) 12:746647. doi: 10.3389/fimmu.2021.746647

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Zheng Q, Yu X, Zhang Q, He Y, Guo W. Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer. Biosci Rep. (2021) 41:BSR20210337. doi: 10.1042/BSR20210337

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Gao L, Chen R, Sugimoto M, Mizuta M, Kishimoto Y, Omori K. The Impact of m1A methylation modification patterns on tumor immune microenvironment and prognosis in oral squamous cell carcinoma. Int J Mol Sci. (2021) 22:10302. doi: 10.3390/ijms221910302

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Potteaux S, Tedgui A. Monocytes, macrophages and other inflammatory mediators of abdominal aortic aneurysm. Curr Pharm Des. (2015) 21:4007–15. doi: 10.2174/1381612821666150826093855

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Raffort J, Lareyre F, Clément M, Hassen-Khodja R, Chinetti G, Mallat Z. Monocytes and macrophages in abdominal aortic aneurysm. Nat Rev Cardiol. (2017) 14:457–71. doi: 10.1038/nrcardio.2017.52

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Cheng Z, Zhou YZ, Wu Y, Wu QY, Liao XB, Fu XM, et al. Diverse roles of macrophage polarization in aortic aneurysm: destruction and repair. J Transl Med. (2018) 16:354. doi: 10.1186/s12967-018-1731-0

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Davis FM, Gallagher KA. Epigenetic mechanisms in monocytes/macrophages regulate inflammation in cardiometabolic and vascular disease. Arterioscler Thromb Vasc Biol. (2019) 39:623–34. doi: 10.1161/ATVBAHA.118.312135

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Song H, Yang Y, Sun Y, Wei G, Zheng H, Chen Y, et al. Circular RNA Cdyl promotes abdominal aortic aneurysm formation by inducing M1 macrophage polarization and M1-type inflammation. Mol Ther. (2022) 30:915–31. doi: 10.1016/j.ymthe.2021.09.017

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. (2019) 37:773–82. doi: 10.1038/s41587-019-0114-2

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Tang D, Han Y, Lun Y, Jiang H, Xin S, Duan Z, et al. Y chromosome loss is associated with age-related male patients with abdominal aortic aneurysms. Clin Interv Aging. (2019) 14:1227–41. doi: 10.2147/CIA.S202188

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Quaye KB, Pack N, Wilson-Byrne T, Long CA. Contemporary management of abdominal aortic aneurysms. Curr Cardiol Rep. (2022) 24:431–8. doi: 10.1007/s11886-022-01662-z

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Zhong L, He X, Song H, Sun Y, Chen G, Si X, et al. METTL3 induces AAA development and progression by modulating N6-Methyladenosine-dependent primary miR34a processing. Mol Ther Nucleic Acids. (2020) 21:394–411. doi: 10.1016/j.omtn.2020.06.005

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Song P, Tayier S, Cai Z, Jia G. RNA methylation in mammalian development and cancer. Cell Biol Toxicol. (2021) 37:811–31. doi: 10.1007/s10565-021-09627-8

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Wu Y, Zhan S, Xu Y, Gao X. RNA modifications in cardiovascular diseases, the potential therapeutic targets. Life Sci. (2021) 278:119565. doi: 10.1016/j.lfs.2021.119565

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Komal S, Zhang LR, Han SN. Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases. Biomed Pharmacother. (2021) 137:111376. doi: 10.1016/j.biopha.2021.111376

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Garagoli F, Fiorini N, Pérez MN, Rabellino JM, Valle Raleigh J, Chas JG, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict in-hospital mortality in symptomatic but unruptured abdominal aortic aneurysm patients. Int Angiol. (2022). [online ahead of print]. doi: 10.23736/S0392-9590.22.04754-X

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Nishibe T, Kano M, Maekawa K, Matsumoto R, Fujiyoshi T, Iwahashi T, et al. Association of neutrophils, lymphocytes, and neutrophil-lymphocyte ratio to overall mortality after endovascular abdominal aortic aneurysm repair. Int Angiol. (2022) 41:136–42. doi: 10.23736/S0392-9590.22.04795-2

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Le T, He X, Huang J, Liu S, Bai Y, Wu K. Knockdown of long noncoding RNA GAS5 reduces vascular smooth muscle cell apoptosis by inactivating EZH2-mediated RIG-I signaling pathway in abdominal aortic aneurysm. J Transl Med. (2021) 19:466. doi: 10.1186/s12967-021-03023-w

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Wang Y, Zhai S, Xing J, He Y, Li T. LncRNA GAS5 promotes abdominal aortic aneurysm formation through regulating the miR-185-5p/ADCY7 axis. Anticancer Drugs. (2022) 33:225–34. doi: 10.1097/CAD.0000000000001090

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Szekanecz Z, Shah MR, Pearce WH, Koch AE. Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin Exp Immunol. (1994) 98:337–43. doi: 10.1111/j.1365-2249.1994.tb06147.x

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Chan WL, Pejnovic N, Hamilton H, Liew TV, Popadic D, Poggi A, et al. Atherosclerotic abdominal aortic aneurysm and the interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 NKT, and helper T cells. Circ Res. (2005) 96:675–83. doi: 10.1161/01.RES.0000160543.84254.f1

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Sánchez-Infantes D, Nus M, Navas-Madroñal M, Fité J, Pérez B, Barros-Membrilla AJ, et al. Oxidative stress and inflammatory markers in abdominal aortic aneurysm. Antioxidants. (2021) 10:602. doi: 10.3390/antiox10040602

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Krishna SM, Li J, Wang Y, Moran CS, Trollope A, Huynh P, et al. Kallistatin limits abdominal aortic aneurysm by attenuating generation of reactive oxygen species and apoptosis. Sci Rep. (2021) 11:17451. doi: 10.1038/s41598-021-97042-8

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Liu S, Li G, Li Q, Zhang Q, Zhuo L, Chen X, et al. The roles and mechanisms of YTH domain-containing proteins in cancer development and progression. Am J Cancer Res. (2020) 10:1068–84.

PubMed Abstract | Google Scholar

43. Zhang B, Jiang H, Dong Z, Sun A, Ge J. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases. Genes Dis. (2021) 8:746–58. doi: 10.1016/j.gendis.2020.07.011

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Li A, Chen YS, Ping XL, Yang X, Xiao W, Yang Y, et al. Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation. Cell Res. (2017) 27:444–7. doi: 10.1038/cr.2017.10

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Shi H, Wang X, Lu Z, Zhao BS, Ma H, Hsu PJ, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. (2017) 27:315–28. doi: 10.1038/cr.2017.15

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Yang Y, Fan X, Mao M, Song X, Wu P, Zhang Y, et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. (2017) 27:626–41. doi: 10.1038/cr.2017.31

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Wakil SM, Ram R, Muiya NP, Mehta M, Andres E, Mazhar N, et al. A genome-wide association study reveals susceptibility loci for myocardial infarction/coronary artery disease in Saudi Arabs. Atherosclerosis. (2016) 245:62–70. doi: 10.1016/j.atherosclerosis.2015.11.019

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Shi X, Cao Y, Zhang X, Gu C, Liang F, Xue J, et al. Comprehensive analysis of N6-Methyladenosine RNA Methylation regulators expression identify distinct molecular subtypes of myocardial infarction. Front Cell Dev Biol. (2021) 9:756483. doi: 10.3389/fcell.2021.756483

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Gao Y, Wang H, Li H, Ye X, Xia Y, Yuan S, et al. Integrated analyses of m(1)A regulator-mediated modification patterns in tumor microenvironment-infiltrating immune cells in colon cancer. Oncoimmunology. (2021) 10:1936758. doi: 10.1080/2162402X.2021.1936758

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Skotsimara G, Antonopoulos A, Oikonomou E, Papastamos C, Siasos G, Tousoulis D. Aortic wall inflammation in the pathogenesis, diagnosis and treatment of aortic aneurysms. Inflammation. (2022). [online ahead of print]. doi: 10.1007/s10753-022-01626-z

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Yuan Z, Lu Y, Wei J, Wu J, Yang J, Cai Z. Abdominal aortic aneurysm: roles of inflammatory cells. Front Immunol. (2020) 11:609161. doi: 10.3389/fimmu.2020.609161

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Gao JP, Guo W. Mechanisms of abdominal aortic aneurysm progression: a review. Vasc Med. (2022) 27:88–96. doi: 10.1177/1358863X211021170

PubMed Abstract | CrossRef Full Text | Google Scholar

53. van der Vorst EPC, Weber C. Novel features of monocytes and macrophages in cardiovascular biology and disease. Arterioscler Thromb Vasc Biol. (2019) 39:e30–e7. doi: 10.1161/ATVBAHA.118.312002

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Mallat Z. Macrophages. Arterioscler Thromb Vasc Biol. (2014) 34:2509–19. doi: 10.1161/ATVBAHA.114.304794

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Davis FM, Daugherty A, Lu HS. Updates of recent aortic aneurysm research. Arterioscler Thromb Vasc Biol. (2019) 39:e83–e90. doi: 10.1161/ATVBAHA.119.312000

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Krettek A, Sukhova GK, Schönbeck U, Libby P. Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells. Am J Pathol. (2004) 165:1571–81. doi: 10.1016/S0002-9440(10)63414-1

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Kugo H, Moriyama T, Zaima N. The role of perivascular adipose tissue in the appearance of ectopic adipocytes in the abdominal aortic aneurysmal wall. Adipocyte. (2019) 8:229–39. doi: 10.1080/21623945.2019.1636625

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Liu S, Zhao Y, Shen M, Hao Y, Wu X, Yao Y, et al. Hyaluronic acid targeted and pH-responsive multifunctional nanoparticles for chemo-photothermal synergistic therapy of atherosclerosis. J Mater Chem B. (2022) 10:562–70. doi: 10.1039/D1TB02000E

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Liu Q, Shan P, Li H. Gambogic acid prevents angiotensin II-induced abdominal aortic aneurysm through inflammatory and oxidative stress dependent targeting the PI3K/Akt/mTOR and NF-κB signaling pathways. Mol Med Rep. (2019) 19:1396–402. doi: 10.3892/mmr.2018.9720

PubMed Abstract | CrossRef Full Text | Google Scholar

60. He J, Li N, Fan Y, Zhao X, Liu C, Hu X. Metformin inhibits abdominal aortic aneurysm formation through the activation of the AMPK/mTOR signaling pathway. J Vasc Res. (2021) 58:148–58. doi: 10.1159/000513465

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Li G, Qin L, Wang L, Li X, Caulk AW, Zhang J, et al. Inhibition of the mTOR pathway in abdominal aortic aneurysm: implications of smooth muscle cell contractile phenotype, inflammation, and aneurysm expansion. Am J Physiol Heart Circ Physiol. (2017) 312:H1110–H9. doi: 10.1152/ajpheart.00677.2016

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Wang Z, Guo J, Han X, Xue M, Wang W, Mi L, et al. Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE(–/–) mice. Cell Biosci. (2019) 9:68. doi: 10.1186/s13578-019-0332-9

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Zheng YH, Tian C, Meng Y, Qin YW, Du YH, Du J, et al. Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. J Cell Physiol. (2012) 227:127–35. doi: 10.1002/jcp.22709

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Zhou M, Wang X, Shi Y, Ding Y, Li X, Xie T, et al. Deficiency of ITGAM attenuates experimental abdominal aortic aneurysm in mice. J Am Heart Assoc. (2021) 10:e019900. doi: 10.1161/JAHA.120.019900

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Ren J, Liu Z, Wang Q, Giles J, Greenberg J, Sheibani N, et al. Andrographolide ameliorates abdominal aortic aneurysm progression by inhibiting inflammatory cell infiltration through downregulation of cytokine and integrin expression. J Pharmacol Exp Ther. (2016) 356:137–47. doi: 10.1124/jpet.115.227934

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Fang L, Ohashi K, Otaka N, Ogawa H, Hiramatsu-Ito M, Kawanishi H, et al. Omentin attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein-E knockout mice. Cardiovasc Res. (2021) cvab179. [online ahead of print]. doi: 10.1093/cvr/cvab179

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Pilecki B, de Carvalho P, Kirketerp-Møller KL, Schlosser A, Kejling K, Dubik M, et al. MFAP4 deficiency attenuates Angiotensin II-Induced abdominal aortic aneurysm formation through regulation of macrophage infiltration and activity. Front Cardiovasc Med. (2021) 8:764337. doi: 10.3389/fcvm.2021.764337

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Ohno T, Aoki H, Ohno S, Nishihara M, Furusho A, Hiromatsu S, et al. Cytokine Profile of Human Abdominal Aortic Aneurysm: Involvement of JAK/STAT Pathway. Ann Vasc Dis. (2018) 11:84–90. doi: 10.3400/avd.oa.17-00086

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Wu QY, Cheng Z, Zhou YZ, Zhao Y, Li JM, Zhou XM, et al. A novel STAT3 inhibitor attenuates angiotensin II-induced abdominal aortic aneurysm progression in mice through modulating vascular inflammation and autophagy. Cell Death Dis. (2020) 11:131. doi: 10.1038/s41419-020-2326-2

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Xiao J, Wei Z, Chen X, Chen W, Zhang H, Yang C, et al. Experimental abdominal aortic aneurysm growth is inhibited by blocking the JAK2/STAT3 pathway. Int J Cardiol. (2020) 312:100–6. doi: 10.1016/j.ijcard.2020.03.072

PubMed Abstract | CrossRef Full Text | Google Scholar

71. Ren J, Han X, Lohner H, Liang R, Liang S, Wang H. Serum- and Glucocorticoid-Inducible Kinase 1 promotes alternative macrophage polarization and restrains inflammation through FoxO1 and STAT3 signaling. J Immunol. (2021) 207:268–80. doi: 10.4049/jimmunol.2001455

PubMed Abstract | CrossRef Full Text | Google Scholar

72. Tian Z, Zeng F, Zhao C, Dong S. Angelicin alleviates post-trauma osteoarthritis progression by regulating macrophage polarization via STAT3 signaling pathway. Front Pharmacol. (2021) 12:669213. doi: 10.3389/fphar.2021.669213

PubMed Abstract | CrossRef Full Text | Google Scholar

73. Ruan W, Ji X, Qin Y, Zhang X, Wan X, Zhu C, et al. Harmine alleviated sepsis-induced cardiac dysfunction by modulating macrophage polarization via the STAT/MAPK/NF-κB pathway. Front Cell Dev Biol. (2021) 9:792257. doi: 10.3389/fcell.2021.792257

PubMed Abstract | CrossRef Full Text | Google Scholar

74. Liang T, Chen J, Xu G, Zhang Z, Xue J, Zeng H, et al. STAT1 and CXCL10 involve in M1 macrophage polarization that may affect osteolysis and bone remodeling in extrapulmonary tuberculosis. Gene. (2022) 809:146040. doi: 10.1016/j.gene.2021.146040

PubMed Abstract | CrossRef Full Text | Google Scholar